Journal Home > Volume 8 , Issue 1

Time is infinite movement in constant motion. We are glad to see that Neurorestoratology, a new discipline, has grown into a rich field involving many global researchers in recent years. In this 2019 yearbook of Neurorestoratology, we introduce the most recent advances and achievements in this field, including findings on the pathogenesis of neurological diseases, neurorestorative mechanisms, and clinical therapeutic achievements globally. Many patients have benefited from treatments involving cell therapies, neurostimulation/neuromodulation, brain–computer interface, neurorestorative surgery or pharmacy, and many others. Clinical physicians can refer to this yearbook with the latest knowledge and apply it to clinical practice.


menu
Abstract
Full text
Outline
About this article

The 2019 yearbook of Neurorestoratology

Show Author's information Hongyun Huang1,2( )Lin Chen3Gengsheng Mao1John Bach4Qun Xue5Fabin Han6Xiaoling Guo7Ali Otom8Elena Chernykh9Edgardo Alvarez10Andrey Bryukhovetskiy11Anna Sarnowaska12Xijing He13Milan Dimitrijevic14Ihsan Shanti15Klaus von Wild16Almudena Ramón-Cueto17Ziad Alzoubi18Gustavo Moviglia19Hamid Mobasheri20Adeeb Alzoubi21Wenchuan Zhang22
Institute of Neurorestoratology, Third Medical Center of General Hospital of PLA, Beijing, China
Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Beijing, China
Department of Neurorestoratology, Tsinghua University Yuquan Hospital, Beijing, China
Center for Ventilator Management Alternatives, University Hospital, Newark, New Jersey, USA
Neurology Department, the First Affiliated Hospital of Soochow University, Suzhou City, Jiangsu, China;
The Institute for Translational Medicine, Affiliated Second Hospital and Liaocheng Hospital in Shandong University, Liaocheng, China;
Neurological Center, 981 Hospital of PLA, Chengde, Hebei, China;
Royal Specialty Center for Spine & M-Skeletal Disorders, Amman, Jordan;
Lab of Cellular Immunotherapy and Institute of Fundamental and Clinical Immunology, Novosibirs, Russia.;
Laboratory of Experimental Neuropsychopharmacology, Medical Sciences, National University of Cuyo, Mendoza, Argentina;
Central Clinical Hospital of the Russian Academy of Science, Russia;
Translational Platform for Regenerative Medicine (PBTMR), Polish Academy of Sciences, Warsaw, Poland;
Xi’an International Rehabilitation Medical Center, Xi’an, Shaanxi, China;
Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, Texas, USA;
American Clinic for Interventional Pain and Spine, Amman, Jordan;
Department of Neurosurgery, Westphalia Wilhelm’s University, Münster, Germany;
Center for Medical Innovation in Medullary Regeneration (CIMERM), Spain;
Jordan Orthopedic and Spine Center, Amman, Jordan;
Wake Forest Institute for Regenerative Medicine of Wake Forest University, North Caroline, USA;
Laboratory of Membrane Biophysics and Macromolecules, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran;
Stem Cells Arabia, Amman, Jordan;
Department of Neurosurgery, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China

Abstract

Time is infinite movement in constant motion. We are glad to see that Neurorestoratology, a new discipline, has grown into a rich field involving many global researchers in recent years. In this 2019 yearbook of Neurorestoratology, we introduce the most recent advances and achievements in this field, including findings on the pathogenesis of neurological diseases, neurorestorative mechanisms, and clinical therapeutic achievements globally. Many patients have benefited from treatments involving cell therapies, neurostimulation/neuromodulation, brain–computer interface, neurorestorative surgery or pharmacy, and many others. Clinical physicians can refer to this yearbook with the latest knowledge and apply it to clinical practice.

Keywords:

yearbook, Neurorestoratology, pathogenesis, neurorestorative mechanism, therapeutic achievement
Received: 04 March 2020 Accepted: 10 March 2020 Published: 23 April 2020 Issue date: March 2020
References(83)
[1]
D Zada, I Bronshtein, T Lerer-Goldshtein, et al. Sleep increases chromosome dynamics to enable reduction of accumulating DNA damage in single neurons. Nat Commun. 2019, 10(1): 895.
[2]
EP Moreno-Jiménez, M Flor-García, J Terreros-Roncal, et al. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med. 2019, 25(4): 554-560.
[3]
MK Tobin, K Musaraca, A Disouky, et al. Human hippocampal neurogenesis persists in aged adults and Alzheimer’s disease patients. Cell Stem Cell. 2019, 24(6): 974-982.e3.
[4]
H Mathys, J Davila-Velderrain, ZY Peng, et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature. 2019, 570(7761): 332-337.
[5]
C Ising, C Venegas, SS Zhang, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019, 575(7784): 669-673.
[6]
SS Dominy, C Lynch, F Ermini, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019, 5(1):eaau3333.
[7]
MV Lourenco, RL Frozza, GB de Freitas, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nat Med. 2019, 25(1): 165-175.
[8]
Z Vrselja, SG Daniele, J Silbereis, et al. Restoration of brain circulation and cellular functions hours post- mortem. Nature. 2019, 568(7752): 336-343.
[9]
GK Anumanchipalli, J Chartier, EF Chang. Speech synthesis from neural decoding of spoken sentences. Nature. 2019, 568(7753): 493-498.
[10]
RN Moda-Sava, MH Murdock, PK Parekh, et al. Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation. Science. 2019, 364(6436): eaat8078.
[11]
BL Heckmann, BJW Teubner, B Tummers, et al. LC3-associated endocytosis facilitates β-amyloid clearance and mitigates neurodegeneration in murine Alzheimer’s disease. Cell. 2019, 178(3): 536-551.e14.
[12]
NE Fultz, G Bonmassar, K Setsompop, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019, 366(6465): 628-631.
[13]
T von Wild, GA Brunelli, KRH von Wild, et al. Regeneration of denervated skeletal muscles – brunelli’s CNS-PNS paradigm. J Med Life. 2019, 12(4): 342-353.
[14]
ML Levy, JR Crawford, N Dib, et al. Phase I/II study of safety and preliminary efficacy of intravenous allogeneic mesenchymal stem cells in chronic stroke. Stroke. 2019, 50(10): 2835-2841.
[15]
GZ Zhang, Y Li, JL Reuss, et al. Stable intracerebral transplantation of neural stem cells for the treatment of paralysis due to ischemic stroke. Stem Cells Transl Med. 2019, 8(10): 999-1007.
[16]
XL Guo, X Wang, Y Li, et al. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review. J Neurorestoratology. 2019, 7(2): 82-88.
[17]
SI Savitz, D Yavagal, G Rappard, et al. A phase 2 randomized, sham-controlled trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-stroke). Circulation. 2019, 139(2): 192-205.
[18]
MC Brunet, SH Chen, P Khandelwal, et al. Intravenous stem cell therapy for high-grade aneurysmal subarachnoid hemorrhage: case report and literature review. World Neurosurg. 2019, 128: 573-575.
[19]
AMA Hammadi, F Alhimyari. Intra-arterial injection of autologous bone marrow-derived mononuclear cells in ischemic stroke patients. Exp Clin Transplant. 2019, 17(Suppl 1): 239-241.
[20]
FS Vahidy, ME Haque, MH Rahbar, et al. Intravenous bone marrow mononuclear cells for acute ischemic stroke: safety, feasibility, and effect size from a phase I clinical trial. Stem Cells. 2019, 37(11): 1481-1491.
[21]
J Vaquero, M Zurita, J Mucientes, et al. Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer’s type dementia. Cytotherapy. 2019, 21(4): 428-432.
[22]
AD Levi, KD Anderson, DO Okonkwo, et al. Clinical outcomes from a multi-center study of human neural stem cell transplantation in chronic cervical spinal cord injury. J Neurotrauma. 2019, 36(6): 891-902.
[23]
M Bydon, AB Dietz, S Goncalves, et al. CELLTOP clinical trial: first report from a phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis due to traumatic spinal cord injury. Mayo Clin Proc. 2020, 95(2): 406-414.
[24]
P Phedy, YP Djaja, L Gatam, et al. Motoric recovery after transplantation of bone marrow derived mesenchymal stem cells in chronic spinal cord injury: a case report. Am J Case Rep. 2019, 20: 1299-1304.
[25]
JJ Moore, JC Massey, CD Ford, et al. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. J Neurol Neurosurg Psychiatry. 2019, 90(5): 514-521.
[26]
A Mariottini, C Innocenti, B Forci, et al. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis. Eur J Neurol. 2019, 26(4): 624-630.
[27]
D Boruczkowski, I Zdolińska-Malinowska. Wharton’s jelly mesenchymal stem cell administration improves quality of life and self-sufficiency in children with cerebral palsy: results from a retrospective study. Stem Cells Int. 2019, 2019: 1-13.
[28]
D Boruczkowski, I Zdolińska-Malinowska. A retrospective analysis of safety and efficacy of Wharton’s jelly stem cell administration in children with spina bifida. Stem Cell Rev And Rep. 2019, 15(5): 717-729.
[29]
K Pan, LN Deng, PY Chen, et al. Safety and feasibility of repeated intrathecal allogeneic bone marrow-derived mesenchymal stromal cells in patients with neurological diseases. Stem Cells Int. 2019, 2019: 8421281.
[30]
C Goudie, AM Alayoubi, P Tibout, et al. Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review. JIMD Rep. 2019, 46(1): 46-51.
[31]
Y Chen, XH Zhang, LP Xu, et al. Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy (in Chinese). Beijing Da Xue Xue Bao Yi Xue Ban. 2019, 51(3):409-413.
[32]
NH Riordan, ML Hincapié, I Morales, et al. Allogeneic human umbilical cord mesenchymal stem cells for the treatment of autism spectrum disorder in children: safety profile and effect on cytokine levels. Stem Cells Transl Med. 2019, 8(10): 1008-1016.
[33]
B Blok, P van Kerrebroeck, S de Wachter, et al. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Neurourol Urodyn. 2019, 38(2): 689-695.
[34]
R McCrery, F Lane, K Benson, et al. Treatment of urinary urgency incontinence using a rechargeable SNM system: 6-month results of the ARTISAN-SNM study. J Urol. 2020, 203(1): 185-192.
[35]
SD Yeh, BS Lin, SC Chen, et al. Effects of genital nerve stimulation amplitude on bladder capacity in spinal cord injured subjects. Evid Based Complement Alternat Med. 2019, 2019: 1248342.
[36]
DJ Bourbeau, KJ Gustafson, SW Brose. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: a pilot feasibility study. J Spinal Cord Med. 2019, 42(3): 360-370.
[37]
AL Benabid, T Costecalde, A Eliseyev, et al. An exoskeleton controlled by an epidural wireless brain- machine interface in a tetraplegic patient: a proof-of- concept demonstration. Lancet Neurol. 2019, 18(12): 1112-1122.
[38]
M Bockbrader, N Annetta, D Friedenberg, et al. Clinically significant gains in skillful grasp coordination by an individual with tetraplegia using an implanted brain-computer interface with forearm transcutaneous muscle stimulation. Arch Phys Med Rehabil. 2019, 100(7): 1201-1217.
[39]
M Seier, A Hiller, J Quinn, et al. Alternating thalamic deep brain stimulation for essential tremor: a trial to reduce habituation. Mov Disord Clin Pract. 2018, 5(6): 620-626.
[40]
A Selfslagh, S Shokur, DSF Campos, et al. Non- invasive, brain-controlled functional electrical stimulation for locomotion rehabilitation in individuals with paraplegia. Sci Rep. 2019, 9(1): 6782.
[41]
SY Fan, KL Wang, W Hu, et al. Pallidal versus subthalamic nucleus deep brain stimulation for levodopa-induced dyskinesia. Ann Clin Transl Neurol. 2020, 7(1): 59-68.
[42]
R Krauth, J Schwertner, S Vogt, et al. Cortico-muscular coherence is reduced acutely post-stroke and increases bilaterally during motor recovery: a pilot study. Front Neurol. 2019, 10: 126.
[43]
DJ Yang, Q Wang, CP Xu, et al. Transcranial direct current stimulation reduces seizure frequency in patients with refractory focal epilepsy: a randomized, double- blind, sham-controlled, and three-arm parallel multicenter study. Brain Stimul. 2020, 13(1): 109-116.
[44]
C Elder, D Friedman, O Devinsky, et al. Responsive neurostimulation targeting the anterior nucleus of the thalamus in 3 patients with treatment-resistant multifocal epilepsy. Epilepsia Open. 2019, 4(1): 187-192.
[45]
BF Yu, YQ Qiu, MX Du, et al. Contralateral hemi- fifth-lumbar nerve transfer for unilateral lower limb dysfunction due to incomplete traumatic spinal cord injury: a report of two cases. Microsurgery. 2020, 40(2): 234-240.
[46]
N van Zyl, B Hill, C Cooper, et al. Expanding traditional tendon-based techniques with nerve transfers for the restoration of upper limb function in tetraplegia: a prospective case series. Lancet. 2019, 394(10198): 565-575.
[47]
JM Khalifeh, CF Dibble, A van Voorhis, et al. Nerve transfers in the upper extremity following cervical spinal cord injury. Part 2: Preliminary results of a prospective clinical trial. J Neurosurg Spine. 2019: 1-13.
[48]
CF Dibble, JM Khalifeh, A VanVoorhis, et al. Novel nerve transfers for motor and sensory restoration in high cervical spinal cord injury. World Neurosurg. 2019, 128: 611-615.e1.
[49]
WB Ding, S Zhang, D Wu, et al. Hand function recovery using nerve segment insert grafting in patients with chronic incomplete lower cervical spinal cord injury: a preliminary clinical report. J Neurorestoratology. 2019, 7(3): 129-135.
[50]
YQ Qiu, MX Du, BF Yu, et al. Contralateral lumbar to sacral nerve rerouting for hemiplegic patients after stroke: a clinical pilot study. World Neurosurg. 2019, 121: 12-18.
[51]
JY Guan, J Lin, XQ Guan, et al. Treatment of central paralysis of upper extremity using contralateral C7 nerve transfer via posterior spinal route. World Neurosurg. 2019, 125: 228-233.
[52]
FR Wu, CY Ng. Sensory nerve transfer for lower roots brachial plexus injury: superficial radial nerve to the dorsal cutaneous branch and the superficial branch of the ulnar nerve. J Hand Microsurg. 2019, 11(3): 178-180.
[53]
RY Kannan, A Hills, MJ Shelley, et al. Immediate compared with late repair of extracranial branches of the facial nerve: a comparative study. Br J Oral Maxillofac Surg. 2020, 58(2): 163-169.
[54]
JC Zang, SH Qin, P Vigneshwaran, et al. The treatment of neurotrophic foot and ankle deformity of spinal bifida: 248 cases in single center. J Neurorestoratology. 2019, 7(3): 153-160.
[55]
WH Jost, L Tatu, S Pandey, et al. Frequency of different subtypes of cervical dystonia: a prospective multicenter study according to Col-Cap concept. J Neural Transm. 2020, 127(1): 45-50.
[56]
P Shieh, K Sharma, B Kohrman, et al. Amifampridine phosphate (Firdapse) is effective in a confirmatory phase 3 clinical trial in LEMS. J Clin Neuromuscul Dis. 2019, 20(3): 111-119.
[57]
Ma H, Campbell BCV, Parsons MW, et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019, 380(19): 1795-1803.
[58]
JF Howard Jr, V Bril, TM Burns, et al. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. 2019, 92(23): e2661-e2673.
[59]
E Shevela, M Davydova, N Starostina, et al. Intranasal delivery of M2 macrophage-derived soluble products reduces neuropsychological deficit in patients with cerebrovascular disease: A pilot study. J Neurorestoratology. 2019, 7(2): 89-100.
[60]
CW Christine, KS Bankiewicz, AD van Laar, et al. Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson’s disease. Ann Neurol. 2019, 85(5): 704-714.
[61]
JD Heiss, C Lungu, DA Hammoud, et al. Trial of magnetic resonance-guided putaminal gene therapy for advanced Parkinson’s disease. Mov Disord. 2019, 34(7): 1073-1078.
[62]
SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, et al. Targeting huntingtin expression in patients with Huntington’s disease. N Engl J Med. 2019, 380(24): 2307-2316.
[63]
J Kim, CG Hu, C Moufawad El Achkar, et al. Patient-customized oligonucleotide therapy for a rare genetic disease. N Engl J Med. 2019, 381(17): 1644- 1652.
[64]
AL Behrman, LC Argetsinger, MT Roberts, et al. Activity-based therapy targeting neuromuscular capacity after pediatric-onset spinal cord injury. Top Spinal Cord Inj Rehabil. 2019, 25(2): 132-149.
[66]
JN Xi, HY Jiang, N Zhang, et al. Respiratory muscle endurance training with normocapnic hyperpnoea for patients with chronic spinal cord injury: a pilot short-term randomized controlled trial. J Rehabil Med. 2019, 51(8): 616-620.
[66]
A Berger, F Horst, F Steinberg, et al. Increased gait variability during robot-assisted walking is accompanied by increased sensorimotor brain activity in healthy people. J Neuroeng Rehabil. 2019, 16(1): 161.
[67]
YH Wei, DC Du, K Jiang. Therapeutic efficacy of acupuncture combined with neuromuscular joint facilitation in treatment of hemiplegic shoulder pain. World J Clin Cases. 2019, 7(23): 3964-3970.
[68]
M Wang, ZL Zhang, X Wang, et al. Clinical trials of acupuncture treatment of post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(8): 605-609.
[69]
YX Duan, ZQ Zhang, XJ Luo, et al. Randomized controlled trial of internal heat-type acupuncture needle therapy in the treatment of post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(3): 205-210.
[70]
YX Duan, ZQ Zhang, XJ Luo, et al. Short-term and long-term therapeutic effects of internal heat-type acupuncture needle therapy combined with acupoint injection of O3 for post-stroke shoulder pain (in Chinese). Zhen Ci Yan Jiu. 2019, 44(1): 51-56.
[71]
M Pradines, M Ghedira, R Portero, et al. Ultrasound structural changes in triceps surae after a 1-year daily self-stretch program: a prospective randomized controlled trial in chronic hemiparesis. Neurorehabil Neural Repair. 2019, 33(4): 245-259.
[72]
tuğba Atan, Ö Özyemİşcİ Taşkiran, A Bora Tokçaer, et al. Effects of different percentages of body weight- supported treadmill training in Parkinson’s disease: a double-blind randomized controlled trial. Turk J Med Sci. 2019, 49(4): 999-1007.
[73]
DJ Edwards, M Cortes, A Rykman-Peltz, et al. Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS. Restor Neurol Neurosci. 2019, 37(2): 167-180.
[74]
ZY Liao, YL Bu, MJ Li, et al. Remote ischemic conditioning improves cognition in patients with subcortical ischemic vascular dementia. BMC Neurol. 2019, 19(1): 206.
[75]
Y Tang, Y Xing, ZD Zhu, et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): a randomized controlled trial. Alzheimers Dement. 2019, 15(5): 605-614.
[76]
WJ Zhao, H You, SR Jiang, et al. Effect of Pro-kin visual feedback balance training system on gait stability in patients with cerebral small vessel disease. Medicine (Baltimore). 2019, 98(7): e14503.
[77]
J Najar, S Östling, P Gudmundsson, et al. Cognitive and physical activity and dementia: a 44-year longitudinal population study of women. Neurology. 2019, 92(12): e1322-e1330.
[78]
JS Rabin, H Klein, DR Kirn, et al. Associations of physical activity and β-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol. 2019, in press, .
[79]
J Marusiak, BE Fisher, A Jaskólska, et al. Eight weeks of aerobic interval training improves psychomotor function in patients with Parkinson’s disease-randomized controlled trial. Int J Environ Res Public Health. 2019, 16(5): E880.
[80]
NM van der Kolk, NM de Vries, RPC Kessels, et al. Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson’s disease: a double- blind, randomised controlled trial. Lancet Neurol. 2019, 18(11): 998-1008.
[81]
L Gao, X Li, DB Wang, et al. Clinical trial of treatment of frozen shoulder by intensive moxibustion plus acupuncture (in Chinese). Zhen Ci Yan Jiu. 2019, 44(4): 297-301.
[82]
UE Syed, A Kamal. Video game-based and conventional therapies in patients of neurological deficits: an experimental study. Disabil Rehabil Assist Technol. 2019: 1-8.
[83]
M Puyade, C Labeyrie, M Badoglio, et al. Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) (in French). Bull Cancer. 2020, 107(1S): S104-S113.
Publication history
Copyright
Rights and permissions

Publication history

Received: 04 March 2020
Accepted: 10 March 2020
Published: 23 April 2020
Issue date: March 2020

Copyright

© The authors 2020

Rights and permissions

This article is published with open access at http://jnr.tsinghuajournals.com

Return